ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0032692;negative regulation of interleukin-1 production;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.65969381209598;6.518977089658987;0.002197570862002862;0.6565011041187423;[IL10, GHSR, IL1R2, TNFAIP3, NLRP12, CEACAM1, NLRP3]
GO:0007253;cytoplasmic sequestering of NF-kappaB;13.0;1.0;0.9625549647676366;9.628524252492122;578.6196231821564;7.8311634786251565;0.019365878064054164;0.8630410292508717;[NFKBIA, IL10, CCDC22]
GO:0032693;negative regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.943860283624253;0.002184000309729388;0.6782296504172152;[CD274, IL23A, PRG2, LILRB1, PDCD1LG2, FCGR2B, DLL1]
GO:1904057;negative regulation of sensory perception of pain;8.0;1.0;0.875;9.628524252492122;66.32592190330784;9.083926447120524;0.0022198689166493682;0.839552420951524;[IL10]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNF, HAVCR2, ACTN4, GREM1, IL23A, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, NOD2, CCL19, CD14, TNFSF14, TNFRSF10B, NLRP12, IL18R1]
GO:0045765;regulation of angiogenesis;6.0;0.7043150770688792;0.675277851124584;8.817594036275793;44.93985318205118;4.1639455212923995;0.0015040964427611868;0.5360646801923071;[SPARC, PLXND1, SERPINE1, CXCL13, AQP1, CDH5, C3AR1, PROK2, CYP1B1, HOXA5, GHSR, HSPG2, SFRP2, HGS, ADAM12, AGTR1, EPHA2, C5AR1, TWIST1, HMOX1, PLCG1, TGFB2, JUP, PLK2, TNFSF12, CXCL10, IL6, ID1, NRP1, ECM1, CD40, ITGB2, TNFAIP3, FASLG, PRL, BRCA1, HHEX, STAB1, CTSH, ITGB8, EMILIN1, CD34, CCR2, IL10, ANXA1, ANXA3, GAB1, SIRT1, F3, DCN, GREM1, CEACAM1, IL1B, CHI3L1, ENG, CX3CR1, PTGS2, THBS2, DLL1, THBS1, GPNMB, CXCR2, E2F2, TIE1, KLF4, LRG1, TEK, PF4]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[PHB2, TNF, CLU, PYCARD, AKT1, TNFSF11, BTK, PRKCQ, S100A8, CARD11, BEX1, TNFRSF11A, NHLH2, NLRP3, S100A12, FZD1, TGFB1, JUP, NFKB1, IL6, COPS5, JMY, MYD88, CD40, ITGB2, CD36, IL10, MYOCD, EDN1, CHUK, ANXA3, NFAM1, IRAK3, TRAF1, GREM1, PSMA6, IL1B, KIT, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0003334;keratinocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;34.35043118565193;7.57984905034425;0.0011496780184027697;0.6778748447945537;[BCL11B, PALLD, SFN]
GO:0001821;histamine secretion;8.0;0.7980440201809971;0.7740220100904985;9.303101852057495;92.71543055810072;7.8311634786251565;0.003103102022309413;0.7754860644832351;[LYN, ADCYAP1, EDN1, BTK]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[IHH, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, BMP2, MAFF, PTPRR, TMEM100, HHEX, EDN1, TIE1]
GO:0071375;cellular response to peptide hormone stimulus;7.0;0.7369933605727446;0.7194160455435727;9.117698628726131;386.0268190343683;4.727217620430932;0.012919970231498398;0.5926694942041391;[CYFIP1, AKT1, PRKACB, MEN1, GHSR, LHCGR, EDN1, ARG1, GLP2R, PRKCD, CCNA2, POR, CEACAM1, ADCY9, PRKAR1B, SLC30A10, FOXO1, PAK1, PRKAR2B, FYN, CSK, TGFB1, CAV1, CDC6, SORBS1, TSHR, NFKB1, NR4A2, NR4A1, NR4A3]
GO:0010536;positive regulation of activation of Janus kinase activity;11.0;1.0;0.9324289523296623;9.628524252492122;2488.7782735422925;7.8311634786251565;0.08329716906043155;0.8329150168128974;[GH1, IL23A, CCL5, IL6R]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[IL10, CD274, CD96, LILRB1, INHBA, PDCD1LG2, GATA3, XCL1, TLR4, HAVCR2]
GO:0044321;response to leptin;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;25.223505691001428;6.943860283624253;8.44208035796484E-4;0.6453503496879909;[CCNA2, EDN1, PID1, NR4A3, SIRT1]
GO:0045779;negative regulation of bone resorption;7.0;1.0;0.8509193652572005;9.628524252492122;83.00611842489866;7.292166977892469;0.002778140083024753;0.7238411236270654;[CALCA, IL6, INPP5D, TNFAIP3, CSK]
GO:0003100;regulation of systemic arterial blood pressure by endothelin;7.0;1.0;0.8509193652572005;9.628524252492122;25.380868944193306;7.9853141584524145;8.494748422630829E-4;0.7592887026755414;[EDN1]
GO:0048016;inositol phosphate-mediated signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;27.814661162170232;6.599019797332524;9.309316775279788E-4;0.6883935445785896;[EDN1]
GO:0051771;negative regulation of nitric-oxide synthase biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.30203964950672;8.390779266560578;0.0049300667038400395;0.7800242071602487;[EDN1]
GO:0048015;phosphatidylinositol-mediated signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;5.649939242635378;8.845336528452411E-4;0.6398575208746181;[CSF1R, PTAFR, GATA3, AKT1, KCNH1, PDGFRB, PDGFRA, EDN1, GSN]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[EPHB2, EPHB1, AP2M1, MMP2, MMP9, EPHA3, EPHA2, SDC2, PAK1, FYN, LYN, PTK2]
GO:0001836;release of cytochrome c from mitochondria;6.0;1.0;0.8231203125901445;9.628524252492122;22.134985108306864;6.686031174322154;7.408380313817617E-4;0.665044257777226;[JUN, BCL2A1, IFI6, SFN, CLU]
GO:0070831;basement membrane assembly;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;38.848171793302654;8.67846133901236;0.0013002133488370917;0.7669372290569613;[LAMC2]
GO:0031583;phospholipase D-activating G-protein coupled receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;9.777073627680469;9.028936615729279E-4;0.8231203125901445;[EDN1]
GO:0034614;cellular response to reactive oxygen species;5.0;0.7671156992804218;0.6737988615011312;9.197741336399668;144.094088465717;5.076593261888053;0.004822699464687224;0.5498582273596049;[TNFAIP3, PTPRK, AQP1, IL18RAP, MYB, AKT1, CYP1B1, PDGFRA, ANXA1, CHUK, ARG1, TPM1, PRKCD, FOS, MMP9, SIRT1, PAX2, DNM2, CCNA2, BTK, PCNA, FOXO1, PDGFD, ECT2, JUN, KLF4, IL6, CDK1, EZH2]
GO:0071801;regulation of podosome assembly;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;64.45443428147517;7.069023426578259;0.002157231910176139;0.7124295520356204;[HCK, GSN, LCP1, TNF]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[ITGB2, PTGS2, TNF, CLU, KLRK1, AKT1, CD36, EDN1, AGXT2, KLF4, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0031581;hemidesmosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;36.796901128588246;7.292166977892469;0.0012315591657128446;0.6960420709600095;[CD151, LAMB3, ITGB4, LAMA3, LAMC2, LAMC1]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, WLS, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, FASLG, NUP62, CCR7, CD36, CHUK, ZDHHC17, IL1B, TLR6, LTF, NOD2, FLNA, FYN, CCL19, CCL21, CARD9, CD4, LTBR]
GO:0045787;positive regulation of cell cycle;5.0;0.5265193887476639;0.5535007062347522;7.230628979693751;42.184038669436575;3.8238302933926853;0.0014118618110960173;0.4857918708913159;[, CCNH, PHB2, CHEK1, AKT1, SOX4, PRKCE, TAS2R13, FLT3LG, MIF, EREG, BTC, CDCA5, TGFA, RACGAP1, SFN, PLK2, CDC6, CD28, CDKN1A, BRCA1, BRCA2, IL10, EDN1, ANXA1, CIT, RAD51C, IL1B, CKS2, PCNA, CXCR5, KCNA5, RANBP2, RANBP1, SVIL, FAP, MAD2L1, CCNT2, CTGF, PDGFRB, CDC25A, CCNE2, CCNE1, CCNB2, CCNB1, ECT2, TGFB2, TGFB1, UBE2C, NDC80, NR4A3, CNOT3, CDK1, NUP62, CCNA2, PSRC1, TFDP1, DTL, SMARCD3, AURKB, E2F1, E2F7, SH2B1, EGF, MEIS2]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[CYR61, IL6R, CTHRC1, MEF2C, JAG1, RUNX2, IL6, BMP2, SFRP2, LTF]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[IL10, CD40, ARG1, SLC11A1, DEFA1, CLEC7A, PF4]
GO:0032308;positive regulation of prostaglandin secretion;10.0;0.8933024483968273;0.861892236059334;9.548481544818586;484.66648287468473;7.474488534686424;0.016221351010299763;0.7974867031240476;[EDN1, IL1B, TNFSF11, TNFRSF11A, MIF, MAP2K6]
GO:0071392;cellular response to estradiol stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;338.1710882258028;6.221725566191056;0.011318281988697268;0.6412996473849828;[IL10, ABCB4, CCNA2, KIF18A, RUVBL2]
GO:0035815;positive regulation of renal sodium excretion;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;135.61946749691032;7.069023426578259;0.004539061527524972;0.7365101867784198;[EDN1, EDNRB, AVPR1A, GNAI2]
GO:0045793;positive regulation of cell size;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;29.63014819255531;7.379178354882098;9.916943946027175E-4;0.7004918368257019;[EDN1]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[CPNE8, NLGN1, CAMK2D, CPNE5, SERPINE1, PHB2, ECT2, KCNH1, MEF2A, MEF2C, JUN, EDN1, FOS, TUBG1, FOSB]
GO:0071398;cellular response to fatty acid;6.0;0.7369933605727446;0.6916169928765168;9.004369943419128;203.00017448222317;5.8067817141283475;0.006794233151624104;0.6200793994936333;[PID1, PTGER2, PTAFR, TNC, P2RY6, CCNB1, E2F1, AKT1, FFAR2, PTGDR, EDN1, DGAT2, PRKCE, NME1, IL1B]
GO:0045672;positive regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;840.7838216260375;6.599019797332524;0.0281402778535103;0.7337148045016781;[CCR1, TMEM64, FOS, TNF, IFNG, IL23A, TNFSF11, IL17A]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, HLA-DPA1, ANXA1, IFNGR1, FOS, SIRT1, F3, FCER2, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3R, F13A1, IL5RA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IL13RA1, IFNA14, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, ITGB2, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL1, BIRC5, LCP1, CX3CR1, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, IL2RB, PTPN6, IL1RN, IFI30, TNFSF11, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, EREG, IFI27, IL23A, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, IL10, SYK, GP1BA, IL17RB, VAV1, HCK, CEACAM1, IL1B, KIT, RHOU, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR2, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, TGFB1, VCAM1, NFKBIA, IL6, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, LTA, CAMK2D, SAMHD1, NCAM1, CD4, LTBR]
GO:0071276;cellular response to cadmium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.139487467954083;0.0026274528238337297;0.6370939872166814;[JUN, GSN, CHUK, FOS, MMP9, AKT1, HMOX1]
GO:0051549;positive regulation of keratinocyte migration;9.0;1.0;0.896240625180289;9.628524252492122;297.9389118084288;7.697632086000634;0.009971747250615804;0.7898978880348613;[ADAM9, MMP9, HBEGF]
GO:0010870;positive regulation of receptor biosynthetic process;7.0;0.8436909121759173;0.7727648213451592;9.466005322994347;258.61903890750995;7.379178354882098;0.008655746490210232;0.728290889492758;[EDN1, HOXA5]
GO:0019229;regulation of vasoconstriction;7.0;0.7369933605727446;0.7194160455435727;9.310070521373587;55.827436365827396;5.500407508664414;0.0018684940537334635;0.6322104610454062;[DOCK5, DOCK4, CHRM1, PTAFR, KCNA5, PTGS2, AKT1, EDN1, ACE, CAV1, F2R, AVPR1A, P2RX1, AGTR1]
GO:0035810;positive regulation of urine volume;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;23.90496242438734;7.138016298065211;8.000775792748091E-4;0.6552794972956795;[BTC, EDN1, EDNRB, GNAI2]
GO:1903672;positive regulation of sprouting angiogenesis;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;183.7504864323888;6.139487467954083;0.00614996341619065;0.6889736746265369;[IL10, GHSR, NRP1, ANXA1, PLK2, PTGS2, KLF4, DLL1, AGTR1, HMOX1]
GO:0022617;extracellular matrix disassembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;37.09213040667776;5.69953618377475;0.0012414402239614005;0.581715557354699;[MMP1, MMP2, LAMC1, MMP8, MMP9, CTSS, MMP12, TIMP2, MMP19, CTSG, TIMP1, LCP1, ELANE]
GO:0090200;positive regulation of release of cytochrome c from mitochondria;9.0;1.0;0.896240625180289;9.628524252492122;472.23248408711356;6.409777797693995;0.015805196260752157;0.7240369598395108;[BIK, MMP9, PYCARD]
GO:0042045;epithelial fluid transport;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;24.0554433753243;7.697632086000634;8.051140412786058E-4;0.6838982747154925;[EDN1, EDNRB, CFTR, AQP1]
GO:0046887;positive regulation of hormone secretion;8.0;0.6393367784920305;0.6946683892460153;8.673012807464685;251.47756009730358;4.909539177224887;0.008416727621346284;0.626074061840201;[MYB, TNFSF11, SOX4, EDN1, PRKCE, ADCYAP1, IL1B, CFTR, BLK, RETN, INHBA]
GO:0002230;positive regulation of defense response to virus by host;8.0;1.0;0.875;9.628524252492122;73.08237040089334;6.599019797332524;0.0024460011674546805;0.712474179321389;[LILRB1, IL23A, IL12RB1]
GO:0046888;negative regulation of hormone secretion;8.0;0.6393367784920305;0.6946683892460153;8.673012807464685;252.0215160505561;5.666199763507158;0.00843493333757307;0.6647697194109919;[GHSR, EDN1, LIF, INHBA, IL1B, FKBP1B]
GO:0043382;positive regulation of memory T cell differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;1160.4929435196905;7.9853141584524145;0.038840654443761495;0.8236103492792612;[IL23A, IL12RB1]
GO:0071385;cellular response to glucocorticoid stimulus;8.0;0.8436909121759173;0.7968454560879586;9.454170865347344;407.2980594846617;5.734022359845919;0.01363189950649617;0.6682381701418294;[FECH, ABCB4, FOXO1, AQP1, EDN1, TGFB1, ANXA1, ARG1, ADCYAP1]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[, PHB2, AKT1, PROK2, PRKACB, PRKCE, PRKCD, PRKAR1B, FPR1, PDGFA, FPR2, SLC30A10, IQGAP3, GATA1, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FZD8, CDC6, AZU1, NOX4, EZH2, CDKN1A, TIMP2, HAVCR2, GPR37, FCRL3, SIRT1, DUSP6, CKS2, HBEGF, ENG, CCL13, PTGS2, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CENPE, PKN1, CCNT2, FMR1, TNF, CLU, CTGF, PYCARD, IFNA14, MAP2K2, IFNA16, F2R, ADCYAP1, ADAM9, IFNA10, CSF1R, TNFRSF11A, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, TREM2, PTPN22, CYR61, XCL1, LCP2, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, RAD50, FCGR2B, IL1RN, CCNH, TCL1A, EDNRB, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, FLT3LG, MIF, EREG, SFRP2, IL23A, EPHA3, EPHA2, TGFA, CCR1, EGR1, LIF, PTK2, MARCO, CD24, IFNA5, IFNA4, NRP1, IFNA7, CD40, IFNA2, CD3E, IFNA8, CCR7, CD36, MAP4K1, EDN1, SYK, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CXCR4, GNAI2, PAK1, CD40LG, CD80, IL6R, PDGFRB, PDGFRA, CALCA, C5AR1, ADRB2, CCNB1, STAP1, ECT2, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, GHR, GRM5, AXIN2, MMP9, GREM1, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0002904;positive regulation of B cell apoptotic process;10.0;0.8436909121759173;0.837086467948879;9.466005322994347;154.91562423562246;8.67846133901236;0.00518488652815606;0.8590579283277371;[IL10]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, IL1RN, CSF3R, C5AR1, ITGB2, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL1, S100A8, PF4]
GO:0010888;negative regulation of lipid storage;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;46.28121162512291;6.8867018697843045;0.001548990502706573;0.6753065664753021;[ABCA1, NR1H2, ITGB3, TNF, NFKBIA, IL6]
GO:0071389;cellular response to mineralocorticoid stimulus;8.0;0.8653626801206646;0.8076813400603323;9.4949928598676;406.8925943765552;7.9853141584524145;0.013618328954222755;0.7833693374183408;[EDN1]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, PRTN3, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, IL1B, KIT, PECAM1, XCL1, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[NRP1, NRP2, ECM1, ITGB3, HMGB2, AKT1, HMOX1, PLCG1, IL10, GHSR, JUN, EGR3, ITGA4, ARG1, CAV2, TNFSF12, SIRT1, F3, NR4A1, BMP2, LRG1, CXCL12, AGTR1, TEK]
GO:0030595;leukocyte chemotaxis;6.0;0.6873818243518346;0.6668112247660618;8.768322987269011;62.06300720445581;4.857092701852345;0.002077192998052941;0.5715122592407831;[CXCL6, CXCL9, IL1RN, CSF3R, ITGB2, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, CXCL16, LGALS3, EDNRB, PDE4B, TNFSF11, FFAR2, CCR7, CCR6, CCR5, IL6R, CCR2, IL10, CXADR, ANXA1, FCER1G, SYK, VAV1, CH25H, IL1B, KIT, XCL1, S100A8, CX3CR1, CCL13, CALCA, C5AR1, CXCR5, CXCR4, TNFRSF11A, CORO1A, CCL8, CXCR1, CCL7, NUP85, CCL5, CXCR2, CCL4, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCR1, CCL23, TGFB2, CCL21, CCL20, AZU1, DEFA1, PPBP, CXCL10, CXCL11, IL6, PF4]
GO:0010460;positive regulation of heart rate;8.0;0.7763722522362496;0.7631861261181248;9.249034630787218;94.35920462208708;6.641579411751319;0.003158117660930423;0.7146506799819907;[EDN1, GCH1, KCNQ1, TPM1, TACR3, AVPR1A]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[FMR1, TNF, SOX4, PPP1R15A, PTAFR, THBS1, CCL5, IL6, LIN28A, CD28, EIF3E, EIF3D]
GO:0045606;positive regulation of epidermal cell differentiation;7.0;0.8653626801206646;0.7836007053175329;9.517298617381897;258.7690385433134;6.641579411751319;0.008660766843029667;0.6905700452391912;[SFRP4, VDR, SFN]
GO:0030073;insulin secretion;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;236.67564318465372;6.166155715036245;0.007921320783140251;0.711578115202808;[IL1RN, ANXA1, ADCYAP1, FKBP1B]
GO:0032494;response to peptidoglycan;5.0;0.8653626801206646;0.7229223519212526;9.461470167828956;77.33766349313319;7.379178354882098;0.002588421997736798;0.6676125360964777;[IL6, C5AR1, CARD9, NLRP3, TREM2, IRAK3, NOD2]
GO:0030072;peptide hormone secretion;8.0;0.6954798709641801;0.72273993548209;8.935377071932177;100.5104884169388;5.75172193694532;0.003363995593748109;0.6691433273378073;[GHSR, IL1RN, EDN1, ANXA1, ADCYAP1, IL6, FKBP1B]
GO:0030195;negative regulation of blood coagulation;8.0;0.7763722522362496;0.7631861261181248;9.387362195675234;250.95291648915588;5.905872616772578;0.008399168271930173;0.6770266002729131;[PDGFRA, EDN1, PROS1, F11, PRKCD, SERPINE1, PDGFA, GP1BA, THBD, CEACAM1, PLAU, CD9, CD34]
GO:0045840;positive regulation of mitotic nuclear division;8.0;0.7140352122741334;0.7320176061370667;9.138976027173417;276.06341799230654;5.75172193694532;0.009239594159256459;0.6691433273378073;[CDCA5, TGFA, PHB2, NUP62, SH2B1, PDGFRB, RANBP2, RANBP1, EDN1, TGFB1, EGF, UBE2C, EREG, BTC, IL1B, CD28]
GO:0006885;regulation of pH;8.0;0.6997970393407541;0.724898519670377;8.992535485772125;35.59382883917596;5.266214121163619;0.0011912934188809815;0.6443144350603088;[LRRK2, FASLG, SLC4A1, SLC4A3, EDNRB, SLC26A11, EDN1, SLC11A1, AVPR1A, CFTR, SLC4A7, SLC26A8, SLC26A7, SLC26A3]
GO:0050873;brown fat cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;6.444869117505266;7.282666309192915E-4;0.6198319182472036;[LAMB3, ADRB2, PTGS2, ALDH6A1, LRG1, PRDM16]
GO:0050871;positive regulation of B cell activation;8.0;0.7436939687323844;0.7468469843661922;9.117698628726131;160.32529438548238;4.695669262696007;0.00536594331968482;0.6151367444652258;[, IGHM, CDKN1A, CD40, TFRC, TNFSF13B, IGHG1, TRBC1, MEF2C, SYK, FCRL3, ATP11C, MIF, MSH6, MSH2, BTK, IGHD, CARD11, NOD2, UNG, IGKC, INPP5D, NCKAP1L, IGHA1, TGFB1, TNFSF13, MLH1, BST1, IL6, PTPRC, BCL6, CD28, CD320]
GO:0051045;negative regulation of membrane protein ectodomain proteolysis;9.0;1.0;0.896240625180289;9.628524252492122;966.2736676900156;7.697632086000634;0.032340310067742455;0.7898978880348613;[IL10, TIMP2, TIMP3, TIMP1]
GO:0072540;T-helper 17 cell lineage commitment;8.0;1.0;0.875;9.628524252492122;46.25983793501841;7.9853141584524145;0.0015482751445338478;0.7833693374183408;[IL6, LY9]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[PYCARD, IFNA14, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, NLRP3, IFNA21, AZU1, DEFA1, CXCL10, IL6, PTPRC, SERINC5, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, IFNG, TLR8, TLR7, UNC93B1, SAMHD1, CARD9, LILRB1]
GO:0033574;response to testosterone;5.0;0.9326813400603323;0.7565816818910864;9.533214072687796;91.03892825708995;6.063501560976162;0.003046990999048697;0.6003287636709002;[THBS1, PLN, EDN1, DUSP1, CAD, NME1, NASP]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H1, MPL, PHB2, SLC8A1, AQP1, AKT1, EDN1, KCND2, PRKCE, SIRT1, CCNA2, TWIST1, PTGS2, CCNB1, E2F1, HMOX1]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, SLC8A1, GRM5, EDNRB, CCRL2, CCR9, TNFSF11, CCR7, CCR6, CCR5, CCR2, EDN1, AVPR1A, ATP1B1, LAT2, BTK, AGTR1, CX3CR1, CAMK2D, CXCR5, CXCR4, FPR2, CXCR6, PLN, CXCR1, CXCR2, DMD, PLCG1, CCR10, CCR1, VCAM1, CCL20, AZU1, SELE, SELP, FKBP1B, LAT]
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway;9.0;0.7436939687323844;0.7680876095464813;9.413412872875176;597.3701724921605;5.233778845410465;0.0199934420750612;0.663896318730187;[LRRK2, CLU, AKT1, MIF, MMP9, SIRT1, SFRP2, NDUFS3, BCL2A1, TAF9, PTGS2, FIGNL1, WFS1, VNN1, CXCL12, SNAI2, GRINA]
GO:0032800;receptor biosynthetic process;6.0;0.8259837884571596;0.7361122068187242;9.318369324188282;73.9644013438808;8.16763571524637;0.002475521949340158;0.7408135829017477;[IL10, TNF]
GO:0046827;positive regulation of protein export from nucleus;9.0;0.811012628672052;0.801746939516315;9.431813958246067;516.7269860224134;6.7325511899570465;0.017294387198074676;0.740543606130341;[IL1B, SFN]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, LYL1, HHEX, LGALS1, BLNK, TPD52, IL10, CR2, IFNA14, ITGA4, IFNA16, NFAM1, ATP11C, MSH2, KIT, CARD11, IFNA10, DLL1, CD79B, CD79A, NKX2-3, IFNA21, VCAM1, CD40LG, BCL6, FCGR2B, ITM2A]
GO:0014032;neural crest cell development;5.0;0.8933024483968273;0.736892236059334;9.510741216835738;64.99956039719687;6.558197802812269;0.002175476790687691;0.6256275524841266;[EDN1, JAG1, SNAI2]
GO:0030185;nitric oxide transport;5.0;1.0;0.7902410118609202;9.628524252492122;43.442191728354636;8.67846133901236;0.0014539710617137646;0.7340579283277371;[EDN1, AQP1]
GO:0060670;branching involved in labyrinthine layer morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;72.98998111856169;7.57984905034425;0.002442908981319996;0.710754145523778;[IL10, SPINT1, FZD5]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IL10, IFNA4, IFNA7, MEF2C, CR2, CD40, IFNA14, IFNA16, IFNA2, CD180, PRKCD, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, MS4A1, CARD11, IFNA21, IFNA10]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, GNS, S100A12, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, PLAU, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, PDCD1LG2, ZAP70, IL23A, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, CD1D, CORO1A, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:1904706;negative regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.8833163751231;6.8867018697843045;0.0027070918088165762;0.7031056191423581;[IL10, CNN1, MEF2C, CDKN1A, MYOCD, TPM1, HMOX1]
GO:0042104;positive regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;649.8896198547563;6.599019797332524;0.021751220713853325;0.7527151911823093;[HHLA2, PYCARD, IL23A, CD24, IL12RB1, IL6R, ICOSLG]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[CX3CR1, EPB41L5, PDGFD, FYN, MEF2C, EDN1, TGFB1, ARG1, CAV1, COL1A1, NOX4, XCL1]
GO:0001516;prostaglandin biosynthetic process;11.0;0.8933024483968273;0.8790801765280758;9.597752593825367;1037.183190875448;7.138016298065211;0.03471358799433119;0.7974674377644215;[EDN1, PNPLA8, MGST1, MIF, PTGS2, PTGS1]
GO:0014826;vein smooth muscle contraction;10.0;1.0;0.9152410118609203;9.628524252492122;72.04955416761116;8.390779266560578;0.002411433737600989;0.8443458537639685;[EDN1, EDNRB]
GO:0035987;endodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;6.444869117505266;7.050676185779127E-4;0.5795909063862833;[LAMB3, ITGB5, ITGA4, COL11A1, MMP2, LAMA3, COL12A1, ITGB2, FN1, LAMB1, INHBA, MMP8, MMP9, COL8A1, ITGA7]
GO:2001258;negative regulation of cation channel activity;9.0;0.7140352122741334;0.7532582313173557;9.100456822291624;527.3235106898757;6.015873511986907;0.017649043342441585;0.7038926763500277;[KCNE3, CAV1, FMR1, MMP9, GEM, FKBP1B, EPHB2, DRD4]
GO:0014824;artery smooth muscle contraction;10.0;0.9326813400603323;0.8815816818910864;9.577230958104572;71.13326343573445;7.697632086000634;0.0023807663114131963;0.8088982747154926;[EDN1]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, EPHB2, PHLDA2, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, IFNA10, CALCA, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IL10, EDN1, GREM1, IFNG, IL1B, LTA, XCL1, SHANK3, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CMTM8, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0014003;oligodendrocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;34.09911675737102;6.558197802812269;0.001141266750656509;0.6256275524841266;[LYN, EIF2B3, TGFB1, GSN, CD9, WASF3]
GO:0060585;positive regulation of prostaglandin-endoperoxide synthase activity;6.0;1.0;0.8231203125901445;9.628524252492122;94.41559583685607;8.67846133901236;0.003160005024139943;0.7669372290569613;[EDN1, NOD2]
GO:0043200;response to amino acid;5.0;0.6441938053840475;0.612337914552944;8.412128928167629;56.712201515420396;5.104244793218563;0.0018981063470534028;0.5512723279577749;[TNF, CTGF, ALAD, PDGFRA, EDN1, CHUK, ARG1, MMP2, COL4A1, NAIP, PCNA, ABCB4, PDGFD, PDGFC, FYN, LYN, COL1A1, COL1A2]
GO:0045742;positive regulation of epidermal growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;233.1839134473908;6.280566066213989;0.0078044557311868065;0.6961884407023742;[EGF, TGFA, FASLG, ARAP1, MMP9, EREG, NUP62, AKT1]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[LGALS1, SKP2, ESCO2, SPARCL1, SDC2, FN1, TF, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, PSMC6, PSMC2, NUCB1, TNC, MEN1, IGFBP5, APLP2, FBXW2, PSMD14, CUL5, SOCS2, IGFBP7, NAE1, WFS1, IL6, COPS5, CCDC22, UBE2M, LAMC1, CYR61, DTL, LAMB1]
GO:0061436;establishment of skin barrier;8.0;1.0;0.875;9.628524252492122;44.874432655588755;6.781341354126479;0.0015019068766151408;0.7217981122146513;[CLDN4, STMN1, SFN]
GO:0045987;positive regulation of smooth muscle contraction;8.0;0.7671156992804218;0.7585578496402109;9.081980546124052;66.30038010178355;6.280566066213989;0.002219014055538479;0.6961884407023742;[GHSR, MYOCD, EDN1, PTAFR, F2R, TACR3, PTGS2, KIT, PROK2]
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;11.0;0.7866048967936545;0.8257314007264895;9.474373572664863;340.6851601099881;5.181953777545879;0.011402425712143147;0.6974343094988531;[CDKN1A, CCNT2, CCNH, TNFAIP3, HHEX, AKT1, MEN1, MYOCD, CDC25A, CCNA2, PSRC1, CCNE2, CCNE1, CKS2, BLM, PKMYT1, CCNB2, CCNB1, SFN, CDKN2C, PLK1, GTF2H1, CDC6, NR2F2]
GO:1904707;positive regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.75549718811011;6.444869117505266;0.0027028138156570515;0.6805102716434839;[IL10, JUN, IGFBP5, MMP2, MMP9, TNF, GNAI2, PAK1, NR4A3]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[CDKN1A, PCNA, CCNB1, E2F1, SFN, E2F7, SOX4, PLK2, TFDP1, CNOT3, CDK1]
GO:0045079;negative regulation of chemokine biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.597752593825367;841.3347014012318;8.67846133901236;0.02815871530382644;0.8188169164668168;[IL6, ELANE]
GO:0042482;positive regulation of odontogenesis;7.0;0.8436909121759173;0.7727648213451592;9.474373572664863;103.86878039186215;7.379178354882098;0.0034763946038822383;0.728290889492758;[BMP2, EDN1, TGFB1, CD34]
GO:2001269;positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;13.0;0.9326813400603323;0.9288956347978027;9.609476057521427;1176.1232083486047;7.474488534686424;0.03936378534126017;0.8448006560307637;[GSN]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, BRCA1, PYCARD, TCL1A, AKT1, EDN1, CHUK, SIRT1, CHI3L1, XCL1, CCL13, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0045191;regulation of isotype switching;9.0;0.7248374789738407;0.7586593646672094;9.398949810847622;201.80341602143696;6.375876246018314;0.0067541787229542785;0.722303232910233;[IL10, CD40, TGFB1, TFRC, TNFSF13, MLH1, UNG, MSH6, MSH2, BCL6, CD28]
GO:2001268;negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;1177.790893893302;8.16763571524637;0.039419601275621635;0.8802482350792397;[MMP9]
GO:1900122;positive regulation of receptor binding;6.0;0.811012628672052;0.7286266269261705;9.117698628726131;48.92057511599705;7.697632086000634;0.0016373276234732048;0.7167775754447168;[NRP1, MMP9]
GO:0030041;actin filament polymerization;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;66.55674193746657;6.409777797693995;0.0022275942554681166;0.6787156999164222;[GSN, ARHGAP6, WASF3]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[, SLA2, F11R, TRBC1, C3AR1, AKT1, PRKACB, WLS, MEF2C, HHLA2, FPR1, PDGFA, FPR3, FPR2, GATA3, SLC30A10, KLRK1, PDGFD, PDGFC, LYN, ABCA1, JUN, JAG1, HLA-DRB4, FN1, VANGL1, COL1A1, COL1A2, HLA-DRB1, SIGLEC9, LRRC4, CTLA4, HLA-DPA1, PTH2R, FOS, SIRT1, F3, LRRC19, PTAFR, KCNA5, PTGS2, FRZB, NTF3, STAT4, FLNA, IL12RB1, IL12RB2, P2RY13, CASP8AP2, P2RY14, USP9Y, TMEM64, HLA-DPB1, LGR4, NCF4, F13A1, CXCL13, CTGF, EFEMP1, AP2M1, LAG3, IFNA14, IFNA16, IFNA10, BLK, CD274, GPR87, TACSTD2, LY96, TNFRSF11A, CORO1A, FOXO1, SOCS2, TNFRSF17, ZNF423, IFNA21, GRIA4, GPR98, TNFRSF10C, TNFRSF10B, BMX, NFKB1, CXCL10, CXCL11, CXCL12, PTPRC, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, ITGB5, ITGB4, LRRK2, ITGB3, ITGB2, FASLG, ITGAL, TNFSF13B, HHEX, FCGR3A, ITGAX, ITGB8, ITGB7, ITGB6, ITGA4, TNFRSF1B, ITGA7, BIRC5, LCP2, LCP1, IL2RG, TSPAN33, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, CTHRC1, TSPAN15, TSPAN13, FCGR2A, IL2RB, PTPN6, CD247, FCGR2B, ICAM2, ICAM3, IFI30, TNFSF11, EPHB2, EPHB1, MIF, EREG, BTC, SFRP4, SFRP2, IFI27, BTK, EPHA3, EPHA2, SDC2, TGFA, CD19, TSPAN5, TSPAN2, CD14, PAG1, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, PPBP, PTK2, ID1, CD28, SDC1, CD24, IGHM, NRP1, PTPRR, NRP2, CD40, TNFRSF13B, GRIK3, CD3G, PTPRK, CD3E, CD3D, CCR9, FCER1A, CD37, CCR7, CCR6, MUC15, CD36, CCR5, CCR2, IL10, FCER1G, SYK, GAB1, RGMA, LAT2, IL1B, KIT, IGHD, GNAI2, PAK1, IGKC, PERP, SORT1, IL18R1, IL17A, CD86, CD80, TRAC, MPL, IHH, CELSR1, CCRL2, IL6R, PDGFRB, CD97, PDGFRA, THEMIS, GEM, OSCAR, CCNE1, CARD11, PSEN2, KIR2DL1, RASGRP4, VCAM1, CAV2, CRIM1, INHBA, GH1, IL6, BMP2, IGKV3-20, SIRPB1, GHR, GRM5, NUP62, MMP1, MMP2, IRAK3, MMP9, BCL2A1, SAMHD1, EGF, MAPK14, CD2, CD4, CD6, CD7, CD9, TEK, CDA, CYFIP1, CLEC10A, EPS8, STMN1, GPR171, HOMER3, DAPK1, PRKCE, PRKCD, HOXB9, DAAM2, PRKCQ, FLRT2, HMOX1, NCKAP1L, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, FZD1, FZD5, FZD8, GP6, SNAI2, CDK14, DENND1B, ITK, CDKN1A, TGFB1I1, ASGR2, TIMP1, ANXA1, IFNGR1, NFAM1, AES, FCER2, HBEGF, ENG, HLA-DQB1, CCL13, ALOX5, CCL19, CCL18, GPR157, CCL23, CCL21, CCL20, CARD9, G0S2, SULF2, ZYX, PLP1, PF4, SEMA5B, CSF3R, PLXND1, FMR1, ITGA2B, IL5RA, TNF, FGF5, PYCARD, CDH5, IGHG1, CDH3, FCGRT, GRAP2, IL13RA2, IL13RA1, TLE4, CLEC4D, ADAM9, CSF1R, CD151, CALCRL, CUL5, IGLV1-44, EIF2B3, BCL6, PLXNB2, CSPG4, LAT, PTPN22, ADAMTS1, CR2, CR1, CHUK, LCK, ESRP1, IL3RA, XCL1, CX3CR1, NOD2, P2RY6, PLN, P2RY2, POLR2E, CSK, POLR2I, POLR2J, POLR2K, POLR2L, SEMA4B, KLF4, P2RX5, P2RX1, MNDA, CLEC2D, IL1RN, EDNRB, ICOSLG, SOX4, ACSL1, IL1R1, IL1R2, FLT3LG, RUNX2, IL23A, TLN1, PFN1, IGSF6, TWIST1, APCDD1, CD79B, CD79A, INPP5D, CCR10, LIF, NMBR, MARCO, IFNA5, ROBO2, IFNA4, IFNA7, IFNA2, PRL, IFNA8, FFAR2, EDN1, GP1BB, GPBAR1, GP1BA, PDCD1LG2, LIME1, IL17RB, VAV1, HCK, CEACAM1, RHOU, TLR4, TLR2, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR2, LILRB1, LILRB2, SORBS1, LILRB3, PODN, KRT19, CD40LG, IL18RAP, ARHGDIA, TSC2, KIF16B, COL4A1, KLRF1, PRTN3, KLRB1, C5AR1, CSF2RB, ADRB2, STAP1, TGFB2, STIL, TGFB1, NR4A2, NFKBIA, NR4A3, FES, KLRD1, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, TMEM100, LRRTM4, BLNK, PDE4B, DCC, GLP2R, AXIN2, DCN, TGFBR3, FGR, ZAP70, IFNG, LTA, CAMK2D, CLEC12B, DLL1, REPS2, S1PR3, NCAM1, TRAT1, TSHR, LTBR]
GO:0042246;tissue regeneration;4.0;0.7586651285174919;0.629332564258746;8.935377071932177;42.88961059103013;6.039404009397101;0.0014354766683382502;0.5588554019015759;[GSN, CCNB1, NINJ1]
GO:1990000;amyloid fibril formation;5.0;1.0;0.7902410118609202;9.628524252492122;65.1103285866179;7.697632086000634;0.0021791841023027143;0.6838982747154925;[GSN, CD36]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CD80, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, IL10, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, ADAM9, TLR4, CX3CR1, CD274, CEBPE, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:0035729;cellular response to hepatocyte growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;78.10713999468214;7.138016298065211;0.00261417568375975;0.6881587980249038;[IL10, NRP1]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[CD86, CD274, CD80, IHH, LRRC32, GPNMB, CTLA4, HAVCR2, IL10, TGFB1, ARG1, PAWR, LILRB1, PDCD1LG2, LILRB2, XCL1, PTPN6, PDE5A]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, SLA2, LGALS3, TRBC1, RNASE6, RNASE3, MIF, SLPI, IL23A, BTK, PADI4, TRIM10, NAIP, GATA3, CD1D, LY9, KLRK1, SLAMF7, S100A12, CD14, IGHA1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QA, LILRA5, IGKC, CARD9, KIR3DL1, LGR4, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, S100A8, IFNA10, BLK, CSF1R, LY96, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, FGR, ZAP70, LCK, LTF, COLEC12, UNC93B1, HIST1H2BK, NLRC4, NOD2, FYN, CSK, CD6, PTX3, PTPN6, CD244]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, UQCRC1, PRKCQ, UQCRC2, ENPEP, GATA3, ADAMTS12, ELANE, BARD1, ST14, ACE, HACE1, PLK1, AZU1, TGFB1I1, MMP28, OLR1, SIRT1, F3, MMP12, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, MMP19, FAM105A, ADAM28, USP1, USP9Y, F11, PSMC6, PSMC2, APEH, IGHG1, RUVBL1, FBXW2, CDC25A, ADAM2, ADAM9, ADAM7, CUL5, IGLV1-44, CLCA4, WFS1, DHCR24, NFKB1, COPS5, CDK1, ADAMTS1, ADAMTS20, DTL, HM13, RNF24, EIF3F, CDC20, ANPEP, SKP2, CFTR, CTSZ, BRCA1, PCSK6, CTSS, CTSH, CTSG, CTSB, MME, RNF144B, C1QA, CD5L, IGKC, PERP, RANBP2, RANBP1, FAP, MAD2L1, IHH, BUB1B, PLAU, PCOLCE, ADAM12, PRTN3, PSMD14, PSEN2, ADRB2, TRHDE, DPP4, CCNB1, NLRP3, TGFB1, UBE2C, NFKBIA, IGKV3-20, TNFAIP3, MMP1, MMP2, MMP8, MMP9, CCNA2, LTF, AURKB, NRIP3, RBMX]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[CCL13, CD40, ADAMTS12, PYCARD, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, EDN1, CCL21, CCL20, KMO, NFKB1, CHI3L1, XCL1, RBMX, IL17A]
GO:0002827;positive regulation of T-helper 1 type immune response;8.0;0.8933024483968273;0.8216512241984136;9.503361109538115;171.8650643746189;6.943860283624253;0.005752169036102488;0.7301093378270707;[ANXA1, SLC11A1, CD80, IL23A, XCL1, CCL19, IL12RB1, IL6R, CCR2]
GO:0070498;interleukin-1-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.845247994956144;0.00101047745553359;0.6498456195510879;[IL1RN, NOD2, EGR1, CHUK, IL1R1, IL1R2, IRAK3, NFKB1, NFKBIA, IL1B, MYD88]
GO:0032695;negative regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.004484905440688;0.002184000309729388;0.6813299963962409;[IL10, LILRB1, IRAK3, THBS1, NFKB1, TLR8]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, EDN1, DAPK1, KIF16B, XCL1, TLR4, TLR2, CCL13, STXBP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, ZYX]
GO:0071901;negative regulation of protein serine/threonine kinase activity;11.0;0.7369933605727446;0.8009256326160346;9.385578073881732;1262.8536775520981;4.8942717050940985;0.0422665760931464;0.6827222349350845;[CDKN1A, TNFAIP3, PTPN22, PYCARD, HHEX, DUSP10, PPP2R1A, NUP62, AKT1, MEN1, DUSP2, MYOCD, DUSP1, PAQR3, PRKCD, IRAK3, SIRT1, DUSP6, SFRP2, PRKAR1B, IL1B, PRKAR2B, SFN, LYN, CDKN2C, CAV1, PLK1, NR2F2, PTPN6, PKIG]
GO:0035722;interleukin-12-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.948432231191374;0.00101047745553359;0.6551224661907153;[STAT4, IL12RB1, IL12RB2, IL10, MIF, IFNG, LCP1]
GO:0042536;negative regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;858.4851481575464;7.9853141584524145;0.0287327253223603;0.7833693374183408;[IL10, GHSR, LILRB1]
GO:0043507;positive regulation of JUN kinase activity;13.0;0.8653626801206646;0.8952363048279688;9.582714716460828;4931.413721535565;5.459585514144159;0.16504997927558432;0.7417584218576596;[IL1RN, TNF, TNFSF11, MAP4K1, EDN1, SYK, MDFIC, IL1B, TLR6, TNFRSF11A, PAK1, CCL19, FZD5, FZD8, CD40LG, PKN1]
GO:0014065;phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;26.42836680105094;6.343086423195323;8.845336528452411E-4;0.6993857346658935;[EDN1, GATA3, AKT1]
GO:0038155;interleukin-23-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.57984905034425;0.00101047745553359;0.738553198190834;[IL23A, STAT4, IL12RB1]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[CSF1R, CD40, IFNA2, GHR, CCL5, FYN, IL6R, LYN, LIF, GH1, IL6, IFNG, IL23A, KIT]
GO:1903923;positive regulation of protein processing in phagocytic vesicle;10.0;1.0;0.9152410118609203;9.628524252492122;819.0285373556242;9.083926447120524;0.027412148067464264;0.8797934328124444;[GSN]
GO:0001542;ovulation from ovarian follicle;4.0;1.0;0.75;9.628524252492122;27.16069640012757;7.697632086000634;9.090440654724862E-4;0.6436572628545723;[ADAMTS1, MMP19, SIRT1]
GO:0002875;negative regulation of chronic inflammatory response to antigenic stimulus;9.0;1.0;0.896240625180289;9.628524252492122;534.5316565980578;9.777073627680469;0.017890293499078287;0.896240625180289;[IL10]
GO:0032966;negative regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;106.39829570052878;7.697632086000634;0.00356105520484733;0.7167775754447168;[CIITA, IL6]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[CYFIP1, NRP1, CPNE5, CXCL16, RPS6KA1, AKT1, EDN1, AVPR1A, SFRP2, MAP1B, S100A8, HBEGF, TAF9, PAK1, SFN, TGFB2, SYT2, FN1, CXCL12]
GO:0032725;positive regulation of granulocyte macrophage colony-stimulating factor production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;7.212124270218933;0.0021737836760178982;0.6919486831672181;[SYK, IL23A, CD80, IL1B]
GO:0051482;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;292.0931097099921;6.139487467954083;0.009776093515261451;0.7620939872166814;[CALCA, EDN1, F2R, C3AR1, AGTR1, GPR18, GPR157, F2RL3]
GO:0045010;actin nucleation;12.0;0.8933024483968273;0.8947715367885583;9.572954401337311;481.27193714664344;6.250713103064308;0.016107738619675037;0.7677820713687393;[GSN, LMOD1, JMY]
GO:0071650;negative regulation of chemokine (C-C motif) ligand 5 production;7.0;1.0;0.8509193652572005;9.628524252492122;88.6386384946749;8.67846133901236;0.002966655460821204;0.7947362817240173;[IL10]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, SLC11A1, IL23A, IL1B, LTA, TLR8, TLR7, TLR4, HSPD1, KLRK1, CD14, IL12RB1, IL12RB2, FZD5, CD2, HLA-DPB1, IL18R1, CD244]
GO:0050715;positive regulation of cytokine secretion;9.0;0.6913464685778243;0.7419138594692012;9.0689084645567;549.4808578036607;5.03214149931722;0.0183906298100222;0.6535845754738829;[ORM1, LRRK2, PTPN22, TNF, PYCARD, CLEC5A, FFAR2, CD34, HAVCR2, IL10, CHUK, SYK, F2R, MIF, IL17RB, MMP12, TLR1, FGR, IL1B, IGHD, TLR8, TLR4, TLR2, CD274, CSF1R, TWIST1, GATA3, NOD2, NLRP3, CD58, CCL19, CD14, FZD5, MAPK14, CD2, NLRP12, CD244, IL17A]
GO:0010259;multicellular organism aging;4.0;0.9326813400603323;0.7163406700301662;9.474373572664863;29.177677042081047;6.943860283624253;9.765505923939418E-4;0.6051093378270707;[EDN1, NDUFS6]
GO:0034105;positive regulation of tissue remodeling;5.0;0.7763722522362496;0.6784271379790451;9.089527751759436;42.28934747447766;6.375876246018314;0.001415386402028971;0.6163036195908642;[TFRC, SYK, VDR, TNFRSF11A, TMEM64, IL23A, TNFSF11]
GO:0034465;response to carbon monoxide;4.0;0.9326813400603323;0.7163406700301662;9.4949928598676;53.4946181105019;8.390779266560578;0.0017904167261278442;0.6791048419030481;[IL10, DNM2]
GO:0032722;positive regulation of chemokine production;6.0;0.7140352122741334;0.6801379187272112;8.734706376470026;66.68357405504983;5.8067817141283475;0.002231839212302133;0.6200793994936333;[CSF1R, TWIST1, TNF, PYCARD, HMOX1, FFAR2, IL6R, HAVCR2, EGR1, AZU1, MIF, ADCYAP1, IL6, IL1B, TLR7, TLR4, TLR2]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BK, C5AR1, HMGB2, TNF, KLRK1, NLRP3, CD36, CAMP, HAVCR2, DEFA4, CARD9, RNASE6, RNASE3, DEFA1, LYZ, FGR, IL6, LTA, MYD88, TLR2]
GO:0051127;positive regulation of actin nucleation;12.0;0.9326813400603323;0.9144609826203107;9.59953671561887;617.551681028286;6.943860283624253;0.02066889900358683;0.8032296504172152;[CYFIP1, GSN]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, MIF, SFRP2, IFNG, IFNA10, PTGS2, PAK1, NTF3, IFNA21, SNCA, TGFB1, CAV1, LIF, IL6]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[SERPINE1, TNF, TNFSF11, FFAR2, CCR7, CCR2, FCER1G, IL17RB, IL23A, IL1B, BTK, AGTR1, LTA, TLR10, TLR7, TLR6, TLR4, S100A8, TLR2, SUCNR1, TNFRSF11A, NOD2, PTGS2, PLA2G7, CNR1, CCL4, S100A12, CCL18, SNCA, CCL23, NFKBIA, NLRP12, IL6, CD6, CD28, MYD88, IL17A]
GO:0045930;negative regulation of mitotic cell cycle;6.0;0.5833093054345528;0.6147749653074209;7.836764783264067;61.236897459641845;4.271742091748107;0.0020495438483445192;0.5415774018184651;[ZWILCH, BUB1B, TNF, CHEK1, KNTC1, SOX4, MSH6, MSH2, AURKAIP1, BLM, CCNB1, NACC2, SFN, NAE1, TGFB1, PLK2, PLK1, CDC6, ZWINT, BCL6, CNOT3, CDK1, EZH2, TOP2A, CDKN1A, BRCA1, TIMP2, TOPBP1, IL10, DUSP1, TFDP1, GAS1, PCNA, AURKB, GPNMB, E2F1, CCL2, BUB1, E2F7, DONSON, KLF4, WEE1, CENPF, FAP, MAD2L1]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[CDKN1A, BCL2A1, BRCA1, BRCA2, TNF, PYCARD, E2F1, HMOX1, SFN, MLH1, TNFRSF1B, SIRT1, MSH6, MSH2, EPHA2]
GO:0009725;response to hormone;4.0;0.5257808277979137;0.5128904138989568;7.033269545535256;21.85620986101781;3.280298637494607;7.315076747364311E-4;0.41775462487096104;[CYFIP1, IL1RN, PID1, SPARC, AQP1, EDNRB, AKT1, PRKACB, PTGDR, MEF2C, PRKCE, PRKCD, EREG, SFRP4, CLDN4, POR, ADCY9, PRKAR1B, SIK1, ABCB4, SLC30A10, GATA1, PRKAR2B, LYN, EGR1, EGR2, JUN, CDC6, NR2F2, COL1A1, SDC1, EZH2, ROBO2, CDKN1A, GABRB1, BRCA2, CTSS, TIMP2, CTSH, TIMP3, CCR7, TIMP1, CTSB, IL10, EDN1, ANXA1, DUSP1, ANXA3, ARG1, TACR3, AVPR1A, FOS, SIRT1, NME1, CEACAM1, IL1B, KIT, MMP19, ACSBG1, ENG, TLR2, YAP1, PCNA, PTGER2, PTAFR, PTGS2, GNAI1, PAK1, CCL19, CCL21, SORT1, SORBS1, FOSB, RAMP1, TNC, IHH, TNF, CTGF, RUVBL2, MEN1, PDGFRB, GHSR, LHCGR, IGFBP5, ADCYAP1, ADAM9, FECH, FOXO1, ACAT1, SOCS2, IGFBP7, CYC1, GAS2L1, EIF2B3, TGFB2, TGFB1, CAV1, DHCR24, INHBA, NFKB1, NR4A2, NR4A1, GH1, IL6, KIF18A, CXCL12, NR4A3, NASP, ALPL, HMGB2, FHL2, GHR, ALAD, HHEX, UQCRFS1, GLP2R, CAD, TGFBR3, CCNA2, RETN, THBS1, P2RY6, PLN, RBBP8, FYN, CSK, TSHR, CD4, TEK]
GO:0045019;negative regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;660.5757278387367;7.292166977892469;0.022108875131204346;0.747921758369865;[IL10, CAV1, CD34]
GO:0032715;negative regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.96654663153603;6.166155715036245;0.002174371849661483;0.6384578026126634;[ORM1, TNFAIP3, PTPN22, TNF, INPP5D, NCKAP1L, CSK, HAVCR2, IL10, GHSR, IRAK3, NLRP12, BANK1, BPI, TLR4]
GO:0051016;barbed-end actin filament capping;13.0;1.0;0.9625549647676366;9.628524252492122;827.5885363368888;7.069023426578259;0.027698643529868262;0.8240651515460564;[EPS8, GSN]
GO:0046597;negative regulation of viral entry into host cell;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;84.95196338807416;6.832634648514029;0.002843265762795464;0.7244212536750128;[GSN, IFNA2, PTX3, TRIM10]
GO:0032717;negative regulation of interleukin-8 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.943860283624253;0.002184000309729388;0.6782296504172152;[IL10, ANXA1, PTPN22, KLF4, BPI, TLR6, ELANE]
GO:0019752;carboxylic acid metabolic process;5.0;0.32428578997777324;0.4523839068498069;5.309370859636751;42.504421911339485;2.9735683700721314;0.0014225847498763097;0.4423094365914798;[, AKT1, CYP1B1, CH25H, MTHFD1, PADI4, ACMSD, PRKAR2B, CYP4F2, CYP4F3, SLC6A6, NOX4, PFAS, ATIC, ELOVL4, ARG1, ELOVL6, ELOVL7, SLC7A5, SLC7A7, SLC7A8, DPYD, ACSBG1, GART, PTGS2, PTGS1, ALOX5, PLP1, SLC16A3, UGT2B15, UGT2B17, PGD, SLC27A3, SLC27A2, GMPS, ACAT1, OSBPL7, AGXT2, CYP4F12, P4HA2, TBXAS1, CSPG4, SERINC5, ETFA, UGT2A3, BPGM, BCAT1, UGT2B28, CYP3A4, SLC25A21, IL1RN, MCCC2, ACSL1, ACSL5, MIF, POR, SUCLG1, MGST1, PKHD1, HAL, ALDH6A1, VNN1, VNN2, VNN3, ALDH18A1, HIBADH, TECR, BRCA1, ACADM, EDN1, SYK, IL1B, TLR2, HSD17B4, GCH1, PNPLA8, NDUFAB1, SCARB2, CPOX, KMO, SLC1A3, GLYAT, TGFB1, NR4A3, GHR, HK3, HIBCH, CYP4A11, CAD, PRODH2, DCN, NDUFS6, EHHADH, SLC3A1, SNCA, MAPK14, SCD]
GO:0034696;response to prostaglandin F;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;73.02034848846884;9.083926447120524;0.00244392534986193;0.8154717862087246;[EDN1]
GO:0061051;positive regulation of cell growth involved in cardiac muscle cell development;10.0;1.0;0.9152410118609203;9.628524252492122;1867.0563873166498;7.697632086000634;0.06248869704183021;0.8088982747154926;[EDN1]
GO:0007193;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.117698628726131;28.36322711391944;5.334422371190153;9.492916862557204E-4;0.6478026081386739;[CHRM2, GABBR1, EDN1, CHRM1, GPR37, HTR1E, NPY1R, GRIK3, FPR2, GNAI1, GNAI2, AKAP12, MARCO, GRM5, ADCY9, RGS1, HRH4, PSAP, FLNA, S1PR3, DRD4]
GO:1902174;positive regulation of keratinocyte apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;8.67846133901236;0.00434501821119318;0.8400575416471059;[SFRP4, GSN]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPARC, SPINT2, PHB2, CYP1B1, EPHB1, SOX7, SOX4, MEF2C, EREG, SFRP4, SFRP2, SPINT1, BTK, GATA3, GATA1, INPP5D, HMOX1, SFN, LYN, JUN, BCL11B, FZD5, LIF, CDC6, NR2F2, NOX4, SNAI2, CDKN1A, TNFRSF13B, TGFB1I1, PRL, PTPRK, BRCA2, LRRC32, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, PAWR, PDCD1LG2, CBFA2T3, NME1, CEACAM1, IL1B, TLR2, PTGS2, ASCL2, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, LILRB1, LILRB2, PODN, FAP, FABP7, DLC1, PKN1, CD86, CD80, SIRPG, IHH, TNF, CDH5, DACH1, MEN1, IGFBP5, F2R, TPM1, TSC2, ADCYAP1, HGS, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, BCL6, OGN, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, LTA, XCL1, PDE5A, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PDGFA, IQGAP3, GATA1, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, JUN, FN1, CDC6, CDKN1A, HOXC10, TIMP1, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, F3, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, CDK1, HPSE, ITGB3, FASLG, CYR61, TNFSF13B, LBH, ITGA4, XCL1, BIRC5, CX3CR1, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, BTC, SFRP2, IL23A, TGFA, TWIST1, CD1D, PKHD1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CCR2, IL10, EDN1, SYK, RHOG, PDCD1LG2, AVPR1A, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, PURA, PAK1, CXCR2, CDX2, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, IL6R, PDGFRB, GHSR, PDGFRA, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, DLL1, THBS1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, GATA1, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, FOSB, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, IL23A, BEX1, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, PRL, BRCA1, CD3D, IL10, EDN1, RGMA, IL1B, TLR4, TLR2, YAP1, SATB2, LILRB1, GRHL2, IL17A, IHH, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, ETV1, DCN, GREM1, ELF3, TAF9, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0060302;negative regulation of cytokine activity;8.0;0.9326813400603323;0.8413406700301662;9.577230958104572;129.49867496184913;9.083926447120524;0.004334204109732123;0.839552420951524;[IL10]
GO:0042313;protein kinase C deactivation;7.0;1.0;0.8509193652572005;9.628524252492122;44.98673222696701;9.777073627680469;0.001505665442206118;0.8509193652572005;[EDN1]
GO:0002740;negative regulation of cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;981.2960148552594;7.9853141584524145;0.03284309450812846;0.8236103492792612;[IL10, LILRB1, TNF]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, PDGFRB, IL10, EDN1, IGFBP5, MMP2, MMP9, EREG, HBEGF, CALCRL, PTAFR, PTGS2, THBS1, GNAI2, PAK1, CCL5, PDGFD, HMOX1, ELANE, JUN, IL6, NR4A3]
GO:0051024;positive regulation of immunoglobulin secretion;9.0;1.0;0.896240625180289;9.628524252492122;579.4559284816147;7.379178354882098;0.019393868449801132;0.7736121494158466;[IL6]
GO:0030889;negative regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.3396801226706;7.004484905440688;0.016946733417578675;0.7544503089863854;[LYN, IL10, TNFRSF13B, PAWR, INPP5D, BTK, CTLA4, MNDA, PKN1, FCGR2B]
GO:0070101;positive regulation of chemokine-mediated signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.577230958104572;306.0943380501704;8.67846133901236;0.010244702027519792;0.8188169164668168;[EDN1, TREM2]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, TNF, AQP1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, FOXO1, IGFBP7, TGFB1, IL6, ALPL, SDC1, FOSB]
GO:0051142;positive regulation of NK T cell proliferation;11.0;1.0;0.9324289523296623;9.628524252492122;1380.3051611134542;8.390779266560578;0.04619757154847237;0.8615337942327104;[IL23A]
GO:0070102;interleukin-6-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.138016298065211;0.00101047745553359;0.7159578506919597;[IL6, IL6R]
GO:0032701;negative regulation of interleukin-18 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.96654663153603;9.083926447120524;0.002174371849661483;0.7876727335416686;[IL10]
GO:0010595;positive regulation of endothelial cell migration;9.0;0.8259837884571596;0.8092325194088689;9.488762310116963;298.6320589889849;5.2552850506314295;0.009994946262957053;0.664996147065328;[NRP1, NRP2, CD40, SPARC, ITGB3, AKT1, EDN1, ANXA1, ANXA3, SIRT1, GATA3, PTGS2, THBS1, HMOX1, PLCG1, TGFB1, PLK2, TEK]
GO:0030886;negative regulation of myeloid dendritic cell activation;7.0;1.0;0.8509193652572005;9.628524252492122;126.51759902192377;8.67846133901236;0.0042344301808169855;0.7947362817240173;[IL10, HAVCR2]
GO:0032269;negative regulation of cellular protein metabolic process;7.0;0.4739867211454891;0.587912725829945;7.449991808168055;289.3917989888356;2.854429736204582;0.009685683076446155;0.4968950347112605;[PID1, SPI1, SERPINE1, SPINT2, AKT1, DAPK1, PRKCE, PRKCD, SPINT1, PRKAR1B, ATF3, FLRT2, PRKAR2B, SFN, NCKAP1L, LYN, JUN, PLK1, NR2F2, PKIG, CDKN1A, SERPINA1, LRRC4, TIMP2, TIMP3, TIMP1, DUSP2, DUSP1, SERPINB9, PAX5, SIRT1, DUSP6, PAX2, GAS1, ENG, SERPINB10, LRRC19, PTGS2, NTF3, DMD, CDKN2C, NR1H2, PKN1, FMR1, PROS1, TNF, PYCARD, MEN1, IGFBP5, FOXO1, SOCS2, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, PTPRC, CNOT3, LRRK2, PTPN22, ALAD, HHEX, DUSP10, EMILIN1, CR1, TNFRSF1B, BIRC5, PPP1R15A, NLRC4, FYN, CSK, KLF4, EIF3E, PTPN6, AQP1, EDNRB, PPP2R1A, RPS6KA1, FBXO5, EPHB2, SOX4, IL1R2, PAQR3, MIF, POR, SFRP2, SLPI, NAIP, TWIST1, TNFSF14, LIF, PTPRR, ECM1, CTSZ, BRCA1, IL10, EDN1, GP1BA, CEACAM1, BANK1, IL1B, TLR4, IFI6, GNAI2, PURA, TM4SF20, PODN, NLRP12, FKBP1B, MAD2L1, APLP2, TSC2, FBLN1, CCNB1, TGFB1, CAV1, CRIM1, EIF2S1, LIN28A, TNFAIP8, TNFAIP3, LRRTM4, NUP62, MYOCD, IRAK3, MMP9, DCN, GREM1, COL6A3, LTF, TAF9, THBS1, SPOCK3, SNCA]
GO:0014050;negative regulation of glutamate secretion;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;415.4544886335298;7.8311634786251565;0.013904887849799128;0.7967266896635242;[IL1RN, IL1B]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[, IL1RN, PHB2, PROK2, TNFSF11, EPHB2, EPHB1, PRKCE, MIF, EPHA3, EPHA2, FPR1, TGFA, PDGFA, FPR2, SLC30A10, IQGAP3, PDGFD, PDGFC, S100A12, ELANE, CCR1, JUN, FZD5, LIF, FZD8, MARCO, NOX4, CD24, EZH2, NRP1, CD40, TIMP2, CCR7, CD36, HAVCR2, MAP4K1, EDN1, GPR37, SYK, FCRL3, DUSP6, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CCL13, CXCR4, GNAI2, PAK1, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CD40LG, PKN1, TNF, CTGF, PYCARD, PDGFRB, PDGFRA, MAP2K2, F2R, ADCYAP1, ADAM9, CSF1R, C5AR1, TNFRSF11A, ADRB2, PSAP, DRD4, MAP2K6, TGFB2, TGFB1, CAV2, GH1, IL6, BMP2, CDK1, CSPG4, LRRK2, TREM2, PTPN22, GHR, CHI3L1, XCL1, PDE5A, NOD2, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, EGF, TIE1, MAPK14, CD4, LTBR, TEK, FCGR2B]
GO:0035094;response to nicotine;4.0;0.9326813400603323;0.7163406700301662;9.446202695698167;26.17342148764107;5.926926025970411;8.760008626412986E-4;0.5531032725983739;[CHRNB4, EDN1, VCAM1, SLC7A11, TNF, NFKB1, CNR1, HMOX1]
GO:0001660;fever generation;7.0;1.0;0.8509193652572005;9.628524252492122;35.726156595412796;8.16763571524637;0.0011957223097949796;0.7686126355688037;[IL1RN, IL1B]
GO:0001781;neutrophil apoptotic process;6.0;1.0;0.8231203125901445;9.628524252492122;45.60457565231589;9.083926447120524;0.0015263441056295624;0.7876727335416686;[IL6]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[INHBA, ADCYAP1, KIT, CTNNA1, MMP19]
GO:0032819;positive regulation of natural killer cell proliferation;9.0;0.9326813400603323;0.8625812952104552;9.589303539338841;506.2743536675314;7.8311634786251565;0.016944546999915155;0.7967266896635242;[IL23A, FLT3LG]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, SPARC, CD80, SERPINE1, CXCL13, PYCARD, EDNRB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, SELP, CXCL10, CXCL11, IL6, ALPL, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, PTGIR, EDN1, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, TLR4, CX3CR1, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:2000660;negative regulation of interleukin-1-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;306.2706419112467;8.16763571524637;0.010250602759086841;0.7926932703116032;[IL6, IL1RN, IL1R2]
GO:0071548;response to dexamethasone;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;124.89021324540595;6.015873511986907;0.004179963043429046;0.6826520511697386;[PCNA, FECH, ABCB4, PTAFR, FOXO1, AQP1, GHSR, EDN1, TGFB1, ARG1, IL1B]
GO:0034392;negative regulation of smooth muscle cell apoptotic process;9.0;0.9326813400603323;0.8625812952104552;9.56398573135455;127.11293359827955;7.9853141584524145;0.004254355493321279;0.8046099625986299;[EDN1]
GO:0043388;positive regulation of DNA binding;5.0;0.7090535922965819;0.6447678080092112;8.578702127993445;32.525455185636034;5.825829909099042;0.0010885977140540058;0.5881742243410422;[HMGB2, TWIST1, GATA3, MYOCD, TGFB1, EGF, KLF4, MMP9, NME1, IFNG]
GO:1903208;negative regulation of hydrogen peroxide-induced neuron death;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;1053.9315577462648;8.16763571524637;0.035274140760945843;0.8329342821725234;[IL10, NR4A3]
GO:0070091;glucagon secretion;9.0;1.0;0.896240625180289;9.628524252492122;103.34370176099773;9.777073627680469;0.003458820694647294;0.896240625180289;[IL6]
GO:0002675;positive regulation of acute inflammatory response;8.0;0.7090535922965819;0.729526796148291;8.971744716103052;164.518653823802;6.518977089658987;0.005506291286306897;0.7083807915285978;[FCER1G, TNFRSF11A, PTGS2, TNF, IL6, CNR1, IL1B, BTK, TNFSF11, FFAR2, CCR7]
GO:0002439;chronic inflammatory response to antigenic stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;42.97336350789415;8.390779266560578;0.0014382798030929574;0.7522251544931926;[IL1RN, IL1B, TNF]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[TNFAIP8, AQP1, RPS6KA1, AKT1, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4]
GO:0043032;positive regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.59742726208806;6.641579411751319;0.004237101960174532;0.6905700452391912;[IL10, ITGAM, LRRK2, ITGB2, THBS1, HSPD1, STAP1, TLR6, TLR4, HAVCR2]
GO:2000676;positive regulation of type B pancreatic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;8.390779266560578;0.00434501821119318;0.8253454670833372;[IL6, EIF2S1]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, CLU, PYCARD, CD36, CCR2, HAVCR2, FCER1G, MIF, TLR1, IL23A, TLR4, TLR2, PTAFR, LY96, TWIST1, NOD2, THBS1, CCL19, CD14, FZD5, CARD9, AZU1, CD2, PF4]
GO:2000553;positive regulation of T-helper 2 cell cytokine production;10.0;1.0;0.9152410118609203;9.628524252492122;874.8811381751227;7.9853141584524145;0.029281484352815565;0.8236103492792612;[IL6, NLRP3, XCL1, GATA3]
GO:0030225;macrophage differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.8867018697843045;0.0015755275618510598;0.6753065664753021;[CSF1R, SPI1, CEBPE, MMP9, SIRT1, NKX2-3]
GO:0042989;sequestering of actin monomers;12.0;1.0;0.9481203125901445;9.628524252492122;480.51094201236833;7.474488534686424;0.016082268797382004;0.8303660038532719;[GSN]
GO:0060271;cilium assembly;6.0;0.8653626801206646;0.7558016526504768;9.405380701177911;137.68250629835126;4.347727998726029;0.00460810957959482;0.5454633246350222;[PKHD1, EHD3, ABLIM3, FLNA, GSN]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, EDN1, CCL21, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, IL23A, IL1B, CXCR2, C3AR1, RAC2, XCL1, CCR7, NCKAP1L, CCL19, PF4]
GO:0010193;response to ozone;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.59609566907567;7.9853141584524145;0.0026640096902085927;0.6986103492792611;[EDN1, IL1B]
GO:1900740;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;990.0589542238915;6.599019797332524;0.033136382202663156;0.7527151911823093;[TFDP1, TP53BP2, E2F1, SFN, YWHAH]
GO:0002690;positive regulation of leukocyte chemotaxis;9.0;0.7508913569872202;0.7716863036738992;9.33127272902419;423.36221235109986;5.288437257948329;0.014169552246136892;0.6666915524892495;[CXCL6, CXCL9, SERPINE1, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, C3AR1, RAC2, CCR7, CCR6, IL6R, CCR2, EDN1, IL23A, IL1B, XCL1, C5AR1, FPR2, PLA2G7, THBS1, CCL7, CCL5, CXCR2, CCL4, CCL1, NCKAP1L, CCL19, S100A14, CCR1, TNFSF14, CCL21, PPBP, MAPK14, CXCL10, CXCL11, IL6, CXCL12, PF4]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, SERPINE1, HP, CXCL13, TNF, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, CLEC4D, SLPI, IL23A, S100A8, SEH1L, C5AR1, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, PRG2, AZU1, DEFA1, PPBP, LYZ, SELP, IL6, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, STAB1, CTSG, CD36, CAMP, HAVCR2, IL10, FCER1G, SYK, ANXA3, TLR1, FGR, IGHD, LTA, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPE, HIST1H2BK, NLRC4, NOD2, IGKC, CCL20, CARD9, CD4]
GO:0007589;body fluid secretion;5.0;0.7980440201809971;0.6892630219514189;8.999915593069748;24.01032294004463;5.514393750639154;8.036039009155507E-4;0.572247364714141;[SLC22A4, CHRM1, ABCB4, PRL, AQP1, SOCS2, ATP7B, EDN1, VDR, CAV1, CAD, NME1]
GO:0044130;negative regulation of growth of symbiont in host;7.0;1.0;0.8509193652572005;9.628524252492122;102.69207226600344;7.212124270218933;0.0034370112418783067;0.7197477358342742;[IL10, LTA, CTSG, CD36, TNF, ELANE]
GO:0001916;positive regulation of T cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.523163736834295;365.14378084230765;6.518977089658987;0.012221033736724321;0.7296214167088868;[CD1E, CD1D, CD1C, CD1B, CD1A, IL23A, XCL1, IL12RB1]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[IL1RN, TNF, PYCARD, CD36, IL6R, FCER1G, F2R, EREG, TLR1, ADCYAP1, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, NOD2, HSPD1, CARD9, LILRB2, IL6, MYD88, IL17A]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[IL1RN, SERPINE1, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, IGFBP5, TPM1, MIF, SFRP2, PADI2, VCL, TACSTD2, KLRK1, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, GREM1, TMEFF2, ENG, CX3CR1, LRP1, THBS1, CCL2, CCL21, TIE1, PODN, KLF4, DLC1]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[SPARC, SERPINE1, MYLK, LGALS3, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, IL23A, PFN1, PDGFA, FPR2, GATA3, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, SIRT1, F3, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CCL21, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, IGFBP5, F2R, ADAM9, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, CXCL10, CXCL11, IL6, BMP2, CXCL12, PTPRC, NR4A3, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, LAMB1, MAPK14, TEK]
GO:0045347;negative regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.30203964950672;8.16763571524637;0.0049300667038400395;0.7686126355688037;[IL10, SPI1, PF4]
GO:0051591;response to cAMP;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;79.54904468548885;5.192106149009898;0.0026624349361310785;0.5886448625081389;[SPARC, PTAFR, AQP9, SLC8A1, AQP1, THBD, JUN, IGFBP5, DUSP1, FOS, NME1, COL1A1, KCNQ1, NDUFS4, NOX4, SDC1, MMP19, FOSB, TEK, SLC26A3, CFTR]
GO:1903903;regulation of establishment of T cell polarity;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;46.402126927956544;8.390779266560578;0.0015530374290757074;0.8041048419030481;[GSN]
GO:0045348;positive regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.9853141584524145;0.0049295844405465;0.7592887026755414;[IL10, CIITA, AZU1, SIRT1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, ASCL2, NR1H2, FOSB, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX7, SOX4, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, EDN1, IL1B, SATB2, CDX2, LOXL2, CHCHD3, CCNE1, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, IFNG, FBP1, AURKB, SNCA, MEIS2]
GO:0010839;negative regulation of keratinocyte proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;86.66714155745981;7.212124270218933;0.002900671232564666;0.7197477358342742;[VDR, SNAI2, SFN, PTPRK]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[SPI1, SPARC, TNC, EEF1B2, ALAD, PRKCE, ADCYAP1, CLDN3, IL1B, CLDN7, S100A8, PSMD14, FECH, GATA3, CCL7, CNR1, FYN, CD14, GSN, VCAM1, CDK1]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[IL10, PCNA, TGFB1, IHH, SULF2, NFKBIA, HMOX1, EZH2]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[CYFIP1, AKT1, IL10, GHSR, CAD, SIRT1, CEACAM1, TLR2, RETN, FOXO1, PAK1, PLN, LYN, EGR1, EGR2, SORT1, SORBS1]
GO:0001569;branching involved in blood vessel morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.375876246018314;0.0017907488225476112;0.6769819729871445;[NRP1, EDN1, PLXND1, IHH, SFRP2, COL4A1, ENG]
GO:0032740;positive regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.23665507211369;7.212124270218933;0.002183412136085803;0.6919486831672181;[TGFB1, IL23A, PRKCQ, NOD2, LY9, MYD88]
GO:0071874;cellular response to norepinephrine stimulus;8.0;1.0;0.875;9.628524252492122;410.2922764159275;8.67846133901236;0.01373211325256535;0.8188169164668168;[IL1RN]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[PCNA, TNFAIP3, FOXO1, AQP1, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, IL6, CDK1, EZH2]
GO:2000330;positive regulation of T-helper 17 cell lineage commitment;14.0;1.0;0.9759193652572005;9.628524252492122;3030.274946811922;8.390779266560578;0.10142057539939929;0.9050242071602486;[IL23A, IL12RB1]
GO:0060298;positive regulation of sarcomere organization;10.0;1.0;0.9152410118609203;9.628524252492122;726.9220736990034;8.390779266560578;0.024329427619312755;0.8443458537639685;[EDN1]
GO:0050829;defense response to Gram-negative bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.407625775213448;0.0023911797157970473;0.627465598881932;[IGHM, HIST1H2BK, SERPINE1, HMGB2, PYCARD, CTSG, IL6R, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, LYZ, SELP, CD4, IL6, IL23A, BPI, TLR4, LTF]
GO:0014891;striated muscle atrophy;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;39.63104934579025;7.57984905034425;0.0013264155559747973;0.710754145523778;[GSN]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[SPI1, TFRC, FMR1, TNF, SLC8A1, AQP1, IL18RAP, CDH1, MYB, CYP1B1, KCNH2, MEF2C, PRKCE, PRKCD, KCNQ1, CFTR, BLM, FECH, ABCB4, FOXO1, PDGFD, HMOX1, ECT2, EGR1, TGFB1, JUP, NFKB1, IL6, ID1, CDK1, EZH2, LRRK2, TNFAIP3, PTPN22, BRCA1, PDE4B, MAP4K1, EDN1, ANXA1, PPP1R12A, ARG1, CAD, SIRT1, PAX2, DNM2, NME1, CCNA2, IL1B, FBP1, PCNA, PTAFR, NOD2, PTGS2, GNAI1, CCL7, CTNNA1, FYN, KLF4, RAD51, CD69]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[TGFB1I1, GATA3, TNF, FOXO1, E2F1, TGFB1, JAG1, SORT1, SIRT1, IL6]
GO:0044267;cellular protein metabolic process;5.0;0.3358520568840654;0.45816704030295297;5.574370570853267;80.86766357206795;1.6585685600933726;0.0027065679235849286;0.3750602851554211;[, POP5, SPI1, SLA2, AKT1, PRKACB, CDCA3, PDGFA, GATA3, FN1, DUSP2, DUSP1, DUSP6, IL12RB2, PKN1, EFEMP1, KCNH1, KCNH2, FBXW2, CDC25A, BLK, PKMYT1, NAE1, BMX, HM13, IL2RG, EIF4H, FYN, IL2RB, EIF3F, CDC20, C1GALT1C1, LGALS1, TNFSF11, SNRPD3, ALG8, BTC, BTK, NAIP, EPB42, SDC2, EGR2, PTK2, MUC15, SPTAN1, SYK, RNF144B, IL1B, KIT, PCNA, KITLG, NDUFAB1, BUB1B, LOXL2, UBE2C, UBE2M, TNFAIP3, GHR, CAD, IRAK3, SHANK3, SPOCK3, TEK, PRKCE, PRKCD, HMBS, PRKCQ, PRDM16, ST3GAL6, IGHA1, BARD1, PLK2, PLK1, ASGR1, ASGR2, TIMP1, CIT, USP1, GSN, ELP4, NUCB1, TNC, IL5RA, TNF, FGF5, LAMP2, MAP2K2, VRK1, NRBP1, FKBP3, MAP2K6, COPS5, P4HA2, CCDC22, LAT, GAL3ST1, CYR61, LCK, TPTE, NLRC4, NOD2, TTR, CSK, PPIL4, PPP2R1A, RPS6KA1, ESCO2, POR, SIK1, CFTR, LIF, PRL, GFRA3, ZDHHC17, HCK, TLR7, TLR4, TLR2, QPCT, NLRP3, CBX4, EIF2S1, KDM5D, DCN, ZAP70, LTF, HIST1H2BK, THBS1, BUB1, SNCA, WEE1, EHMT2, MYLK, KRTCAP2, MEF2A, MEF2C, HSPG2, PRKAR1B, PADI2, SPARCL1, PADI4, UQCRC2, IQGAP3, LYN, ABCA1, HACE1, LYZ, EZH2, SIRT1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, USP9Y, PSMC6, PSMC2, CCNT2, F13A1, RUVBL2, RUVBL1, AP2M1, S100A8, FOXO1, SOCS2, NFKB1, PTPRE, PTPRC, ST6GALNAC2, LRRK2, UTY, DSP, PPP1R12A, BIRC5, DTL, PPP1R15A, CCL8, CCL5, CCL2, NDUFA7, TIE1, PTPN6, CCNH, EPHB2, EPHB1, PAQR3, EREG, ALPK2, EPHA3, EPHA2, TF, PTPRR, FKBP14, SUV39H1, PTPRK, BRCA1, BRCA2, BMI1, CTSH, CTSG, CCR5, PDZRN3, PAK1, PRKY, PPP1CA, FKBP1B, GXYLT2, PDGFRB, PDGFRA, CCNE1, CALCA, KLHL14, PSMD14, PSEN2, RASGRP4, SPTA1, CCNB1, CLK4, CLK1, IL6, BMP2, LAMC1, MMP1, MMP2, CCNA2, TAF9, AURKB, GALNT7, GALNT6, EGF, LAMB1, MAPK14, TAF5, DAPK1, CDK14, ITK, SERPINA1, ANXA1, HBEGF, FAM105A, GTF2H1, CHRM1, ABHD12, GRAP2, MACROD2, STK32B, MEN1, IGFBP5, MELK, CSF1R, CUL5, NACC2, IGFBP7, WFS1, MARCH3, MARCH1, CDK1, PTPN22, DUSP10, CHUK, IL3RA, RNF24, CHEK1, SKP2, BCL11A, MAP4K1, B3GNT5, SGK1, RANBP2, CAMK4, GALNT14, ARID4A, ARID4B, FBL, APLP2, CSF2RB, ADRB2, TGFB2, TGFB1, NFKBIA, FES, TGFBR3, FGR, EHHADH, CAMK2D, NCAM1]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[IL1RN, PRL, THBD, TGFB1, IGFBP5, CAD, FOS, ADCYAP1, CLDN4, PNOC, FOSB]
GO:0045355;negative regulation of interferon-alpha biosynthetic process;8.0;1.0;0.875;9.628524252492122;856.9810707607687;9.083926447120524;0.028682385205471922;0.839552420951524;[IL10]
GO:0043179;rhythmic excitation;8.0;1.0;0.875;9.628524252492122;31.31254140744729;9.777073627680469;0.0010480025814495594;0.875;[EDN1]
GO:0007205;protein kinase C-activating G-protein coupled receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;6.444869117505266;9.028936615729279E-4;0.6527112189764278;[EDN1, CHRM1, LRP1, F2R, AZU1, DGKZ]
GO:1903906;regulation of plasma membrane raft polarization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;31.3480583497322;9.777073627680469;0.0010491913015446624;0.8231203125901445;[GSN]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[CD40, HSPD1, CCR7, CD36, CCL19, MAPK14, CD40LG, IFNG, IL23A, TLR4, TLR2]
GO:0002548;monocyte chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;125.46101547564297;6.039404009397101;0.004199067280386423;0.6597747671587765;[CCL13, CCL23, CALCA, ANXA1, CCL21, CCL20, TNFRSF11A, LGALS3, IL6, CCL8, CCL7, CCL5, CCL4, TNFSF11, CCL2, XCL1, S100A12, CCL1, CCL19, CCL18, IL6R, CCR2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, MEF2C, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, GATA1, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, AZU1, SNAI2, CDKN1A, CHL1, TIMP1, ANXA1, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, PF4, TNF, CLU, CLEC5A, F2R, ADCYAP1, MSH2, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, CXCL12, COPS5, BCL6, CDK1, MYD88, LRRK2, FHL2, FASLG, CYR61, TNFRSF1B, ADAMTS20, BIRC5, CX3CR1, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, IL1RN, SLC46A2, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, NRP1, BRCA1, CTSH, CCR7, CCR5, IL10, EDN1, FCER1G, HCK, RNF144B, CEACAM6, IL1B, KIT, YAP1, IFI6, GNAI2, CXCR2, PDPN, CTNNA1, LILRB1, CD40LG, GRINA, MAD2L1, IHH, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, STIL, CBX4, CAV1, NR4A2, NFKBIA, IL6, NR4A3, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, MMP9, GREM1, NDUFS3, LTF, BCL2A1, TAF9, DLL1, THBS1, AURKB, HSPD1, SNCA, TEK]
GO:0051593;response to folic acid;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;113.95729645358138;7.379178354882098;0.003814048157392989;0.728290889492758;[GSN]
GO:1903909;regulation of receptor clustering;7.0;0.7763722522362496;0.7391054913753253;9.223059144383958;31.620112264749665;7.57984905034425;0.0010582967012476693;0.738553198190834;[TGFB1, GSN]
GO:0042098;T cell proliferation;6.0;0.7248374789738407;0.6855390520770648;9.081980546124052;51.294476028837884;6.343086423195323;0.0017167799506538708;0.647506047256038;[CD151, FYN, TNFSF14, SLC11A1, LILRB1, IL23A, FKBP1B]
GO:0034116;positive regulation of heterotypic cell-cell adhesion;6.0;1.0;0.8231203125901445;9.628524252492122;52.08961109106789;7.212124270218933;0.001743392405611612;0.6919486831672181;[IL10, CEACAM6, IL1B, TNF]
GO:0034115;negative regulation of heterotypic cell-cell adhesion;8.0;1.0;0.875;9.628524252492122;130.132988179366;7.57984905034425;0.004355434002277579;0.7626338329336335;[IL10, IL1RN, KLF4]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, FCER1G, NOD2, HSPD1, PYCARD, CD40LG, IL23A, CD28, XCL1, TLR4, CD34, TLR2]
